QuidelOrtho Corporation
QDELHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeQuidelOrtho Corporation provides diagnostic testing solutions. At a $941.5M market cap, QuidelOrtho Corporation ranks as a small-cap company within healthcare. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units.
Market Cap
$941.5M
Beta
0.78
P/E (TTM)
—
P/E (Fwd)
9.62
EPS (TTM)
$-15.39
EPS (Fwd)
$1.43
ROE
-45.9%
ROA
0.4%
Cash
$123.4M
Total Debt
$3.08B
Free CF
$146.8M
52W Change
-53.4%
Annual Financials
Cash vs Debt
Where QDEL stands vs its 150-day and 200-day moving averages
As of the October 16, 2026 close, QDEL finished 1.14% below its 150-day moving average ($14.07) and 19.41% below its 200-day moving average ($17.26). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is QDEL overbought or oversold?
At the October 16, 2026 close, QDEL's RSI(14) was 77.5, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, QDEL has $123.4M in cash with $3.08B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $146.8M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at -45.9%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 0.4% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $3.27B (2022) to $2.73B (2025), a 16% decline worth watching.
QuidelOrtho Corporation carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. No single metric tells the full story. Reviewing QDEL's risk profile alongside its fundamentals and technical indicators provides a more complete picture.